These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8353318)

  • 21. Oxygen transport in thin layers of packed sickle erythrocytes.
    Liu CY; Udden MM; Hellums JD
    Microvasc Res; 1995 Jan; 49(1):78-96. PubMed ID: 7746165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular polymerization. Disease severity and therapeutic predictions.
    Noguchi CT; Rodgers GP; Schechter AN
    Ann N Y Acad Sci; 1989; 565():75-82. PubMed ID: 2476066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiological-based approaches to treatment of sickle cell disease.
    Steinberg MH; Brugnara C
    Annu Rev Med; 2003; 54():89-112. PubMed ID: 12359829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular crowding limits the role of fetal hemoglobin in therapy for sickle cell disease.
    Rotter M; Aprelev A; Adachi K; Ferrone FA
    J Mol Biol; 2005 Apr; 347(5):1015-23. PubMed ID: 15784260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia?
    Vekilov PG
    Br J Haematol; 2007 Oct; 139(2):173-84. PubMed ID: 17897293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dense red blood cell and oxygen desaturation in sickle-cell disease.
    Di Liberto G; Kiger L; Marden MC; Boyer L; Poitrine FC; Conti M; Rakotoson MG; Habibi A; Khorgami S; Vingert B; Maitre B; Galacteros F; Pirenne F; Bartolucci P
    Am J Hematol; 2016 Oct; 91(10):1008-13. PubMed ID: 27380930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sickle Cell Hemoglobin.
    Mandal AK; Mitra A; Das R
    Subcell Biochem; 2020; 94():297-322. PubMed ID: 32189305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free heme and the polymerization of sickle cell hemoglobin.
    Uzunova VV; Pan W; Galkin O; Vekilov PG
    Biophys J; 2010 Sep; 99(6):1976-85. PubMed ID: 20858444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of polymerization tendency on haematological, rheological and clinical parameters in sickle cell anaemia.
    Keidan AJ; Sowter MC; Johnson CS; Noguchi CT; Girling AJ; Stevens SM; Stuart J
    Br J Haematol; 1989 Apr; 71(4):551-7. PubMed ID: 2469459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.
    Poillon WN; Kim BC; Castro O
    Blood; 1998 Mar; 91(5):1777-83. PubMed ID: 9473246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurements of red cell deformability and hydration reflect HbF and HbA
    Parrow NL; Tu H; Nichols J; Violet PC; Pittman CA; Fitzhugh C; Fleming RE; Mohandas N; Tisdale JF; Levine M
    Blood Cells Mol Dis; 2017 Jun; 65():41-50. PubMed ID: 28472705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
    Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
    Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.
    Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR
    Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of sickle-cell haemoglobin polymerisation under electrochemical control.
    Iqbal Z; Li M; McKendry R; Horton M; Caruana DJ
    Chemphyschem; 2013 Jul; 14(10):2143-8. PubMed ID: 23703945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity.
    Noguchi CT; Torchia DA; Schechter AN
    J Clin Invest; 1983 Sep; 72(3):846-52. PubMed ID: 6886006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.
    Poillon WN; Kim BC; Rodgers GP; Noguchi CT; Schechter AN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5039-43. PubMed ID: 7685112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology.
    Hebbel RP
    Blood; 1991 Jan; 77(2):214-37. PubMed ID: 1985689
    [No Abstract]   [Full Text] [Related]  

  • 40. Electrical Impedance Characterization of Erythrocyte Response to Cyclic Hypoxia in Sickle Cell Disease.
    Liu J; Qiang Y; Alvarez O; Du E
    ACS Sens; 2019 Jul; 4(7):1783-1790. PubMed ID: 31083931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.